Davenport & CO LLC Biomarin Pharmaceutical Inc Transaction History

Davenport & CO LLC

$16 Billion
Q2 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 20, 2023	BUY	$86.68 - $100.3 $26,524 - $30,691	306 Added 6.43%	5,063 $438,000
Q1 2023 Apr 27, 2023	SELL	$87.74 - $117.27 $149,158 - $199,359	-1,700 Reduced 26.33%	4,757 $462,000
Q4 2022 Jan 20, 2023	BUY	$80.93 - $108.63 $24,683 - $33,132	305 Added 4.96%	6,457 $0
Q3 2022 Oct 11, 2022	SELL	$82.16 - $96.94 $35,986 - $42,459	-438 Reduced 6.65%	6,152 $522,000
Q2 2022 Jul 18, 2022	BUY	$71.48 - $86.85 $31,737 - $38,561	444 Added 7.22%	6,590 $546,000
Q1 2022 May 02, 2022	BUY	$74.28 - $92.69 $20,129 - $25,118	271 Added 4.61%	6,146 $474,000
Q4 2021 Feb 10, 2022	BUY	$71.72 - $91.47 $421,355 - $537,386	5,875 New	5,875 $519,000
Q1 2021 Apr 28, 2021	SELL	$74.73 - $90.69 $376,938 - $457,440	-5,044 Closed	0 $0
Q4 2020 Jan 13, 2021	SELL	$72.61 - $90.2 $6,171 - $7,667	-85 Reduced 1.66%	5,044 $442,000
Q3 2020 Oct 15, 2020	SELL	$71.87 - $131.03 $82,003 - $149,505	-1,141 Reduced 18.2%	5,129 $390,000
Q2 2020 Jul 28, 2020	BUY	$79.55 - $124.22 $10,500 - $16,397	132 Added 2.15%	6,270 $773,000
Q1 2020 May 05, 2020	BUY	$71.37 - $96.85 $64,946 - $88,133	910 Added 17.41%	6,138 $519,000
Q4 2019 Jan 22, 2020	SELL	$64.27 - $86.37 $99,554 - $133,787	-1,549 Reduced 22.86%	5,228 $442,000
Q3 2019 Oct 16, 2019	SELL	$67.4 - $85.11 $10,110 - $12,766	-150 Reduced 2.17%	6,777 $580,000
Q2 2019 Jul 10, 2019	BUY	$80.35 - $93.9 $156,843 - $183,292	1,952 Added 39.24%	6,927 $593,000
Q1 2019 Apr 17, 2019	BUY	$84.2 - $98.62 $3,957 - $4,635	47 Added 0.95%	4,975 $442,000
Q4 2018 Jan 28, 2019	SELL	$80.14 - $106.07 $290,106 - $383,973	-3,620 Reduced 42.35%	4,928 $420,000
Q3 2018 Oct 11, 2018	BUY	$93.92 - $105.72 $17,844 - $20,086	190 Added 2.27%	8,548 $829,000
Q2 2018 Jul 09, 2018	BUY	$76.01 - $99.03 $29,795 - $38,819	392 Added 4.92%	8,358 $787,000
Q1 2018 Apr 04, 2018	BUY	$77.67 - $92.63 $340,349 - $405,904	4,382 Added 122.27%	7,966 $646 Million
Q4 2017 Jan 17, 2018	BUY	$80.76 - $95.13 $289,443 - $340,945	3,584	3,584 $320 Million

Others Institutions Holding BMRN

# of Institutions

632

Shares Held

185M

Call Options Held

1.63M

Put Options Held

1.2M

Black Rock Inc. New York, NY

22.7M
Shares

$1.6 Billion
0.04% of portfolio
Vanguard Group Inc Valley Forge, PA

19M
Shares

$1.34 Billion
0.03% of portfolio
Primecap Management CO Pasadena, CA

18.8M
Shares

$1.33 Billion
1.14% of portfolio
Dodge & Cox San Francisco, CA

13.9M
Shares

$983 Million
0.72% of portfolio
Capital Research Global Investors Los Angeles, CA

9.69M
Shares

$684 Million
0.18% of portfolio

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $13.1B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Davenport & CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Davenport & CO LLC with notifications on news.

Account